PSI FAQs: How do PSI CRAs support clinical site relationships?

At PSI, your last patient in is our first priority. Keeping this goal in mind is only possible with dedicated Clinical Research Associates (CRAs) that support your trial from end to end. This stability not only streamlines communication and transparency with your team but also with the sites who are critical to the success of your trial.

Each site on your study will have a single point of contact with one of our highly qualified CRAs, who serves as a site manager. This CRA’s responsibilities include:

• Ensuring sites are up to date and have all the essential documents
• Maintaining a deep working knowledge of the latest protocol version
• Confirming standards of care and investigator interest
• Ensuring a streamlined process of reporting
• Liaising with investigators and clinical research personnel
• Responding to site questions and providing regular remote follow-up in between visits

With experience working with 4,000 sites worldwide, we recognize that building relationships with investigators and site teams takes time. To ensure the success of each site relationship, our CRAs receive extensive project-specific and soft skills training. This difference between managing site relationships and simply monitoring sites can have a direct impact on the success of your current trial as well as a site’s willingness to work with a sponsor or CRO again in the future.

At PSI, we recognize that every patient counts. That’s why our CRAs go the extra mile to ensure our sites receive the support they need so that your study enrolls on time. Contact us today to learn more.

“I would like to thank you from the bottom of my heart for working so diligently for this patient. I know it was a lot of hard work by everyone but if you could have seen the patient’s face when I told her our site was activated it was worth it.”

About Us

For 25 years, we have built trusted relationships with biotech sponsors, with 90% of our customers being repeat and referral. 

Case Study

A sponsor of a pivotal Phase 3 prostate cancer study investigating a radiopharm product approached PSI for support based on our experience and established network of 300 global radiopharmaceutical sites. 

Global Reach

Clinical trial sponsors working in oncology, hematology, IBD, infectious diseases, multiple sclerosis, and many rare diseases rely on PSI’s guidance and experience. 

The PSI Advantage

For the sixth year in a row, PSI CRO has been named a CRO Leadership Award winner in the categories of Expertise, Quality, and Reliability in the Overall (combined Big and Small pharma) respondent group. The CRO Leadership Awards are presented by Life Sciences Leader and Clinical Leader based on research conducted by ISR Reports. The awards recognize CROs that are voted by sponsors to meet or exceed expectations.